Kinases as potential targets for treatment of pulmonary hypertension and right ventricular dysfunction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Kinases as potential targets for treatment of pulmonary hypertension and right ventricular dysfunction

Published:2020-02-04 Issue:1 Volume:178 Page:31-53
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Weiss Astrid¹²,Boehm Mario¹²,Egemnazarov Bakytbek³,Grimminger Friedrich¹²,Savai Pullamsetti Soni⁴,Kwapiszewska Grazyna³⁵,Schermuly Ralph T.¹

Affiliation:

1. Department of Internal Medicine Justus‐Liebig University Giessen Giessen Germany

2. German Center for Lung Research (DZL) Giessen Germany

3. Ludwig Boltzmann Institute for Lung Vascular Research Graz Austria

4. Department IV Max‐Planck Institute for Heart and Lung Research Bad Nauheim Germany

5. Otto Loewi Center, Physiology Medical University of Graz Graz Austria

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14919

Reference155 articles.

1. Long-Term Treatment With a Rho-Kinase Inhibitor Improves Monocrotaline-Induced Fatal Pulmonary Hypertension in Rats

2. Long-Term Inhibition of Rho-kinase Ameliorates Hypoxia-Induced Pulmonary Hypertension in Mice

3. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors

4. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors

5. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Le facteur de croissance des nerfs (NGF) dans l’hypertension pulmonaire (HTP);Revue des Maladies Respiratoires;2024-04

2. Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management;Journal of Clinical Medicine;2024-03-09

3. Comparative Multi-omic Mapping of Human Pancreatic Islet Endoplasmic Reticulum and Cytokine Stress Responses Provides Insights into Type 2 Diabetes Genetics;2024-02-21

4. IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension;Pulmonary Circulation;2024-01

5. Pulmonary Hypertension: Unveiling Molecular Mechanisms, Diagnosis, and Therapeutic Targets;Journal of Personalized Medicine;2023-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3